Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.

Saber S, Mahmoud AAA, Goda R, Helal NS, El-Ahwany E, Abdelghany RH.

Toxicol Lett. 2018 Oct 1;295:32-40. doi: 10.1016/j.toxlet.2018.05.036. Epub 2018 May 31.

PMID:
29859236
2.

Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression.

Liu Y, Zhang Y, Wang S, Dong QZ, Shen Z, Wang W, Tao S, Gu C, Liu J, Xie Y, Qin LX.

Hepatology. 2017 Dec;66(6):1894-1909. doi: 10.1002/hep.29337.

PMID:
28646551
3.

Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.

Van TM, Polykratis A, Straub BK, Kondylis V, Papadopoulou N, Pasparakis M.

J Clin Invest. 2017 Jun 30;127(7):2662-2677. doi: 10.1172/JCI92508. Epub 2017 Jun 19.

4.

Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection.

Wu TJ, Chang SS, Li CW, Hsu YH, Chen TC, Lee WC, Yeh CT, Hung MC.

Clin Cancer Res. 2016 Apr 1;22(7):1800-12. doi: 10.1158/1078-0432.CCR-15-0780. Epub 2015 Dec 11.

5.

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.

Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, Burdelya LG, Grossniklaus HE.

Oncotarget. 2016 Jan 19;7(3):2936-50. doi: 10.18632/oncotarget.6500.

6.

STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.

Li W, Xiao J, Zhou X, Xu M, Hu C, Xu X, Lu Y, Liu C, Xue S, Nie L, Zhang H, Li Z, Zhang Y, Ji F, Hui L, Tao W, Wei B, Wang H.

J Clin Invest. 2015 Nov 2;125(11):4239-54. doi: 10.1172/JCI81203. Epub 2015 Oct 12.

7.

Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells.

Jiang Y, Zhu Y, Wang X, Gong J, Hu C, Guo B, Zhu B, Li Y.

Oncotarget. 2015 Apr 20;6(11):9409-19.

8.

Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-κB activation and MMP-9 expression.

Kim A, Yim NH, Im M, Jung YP, Kim T, Ma JY.

Oncol Rep. 2014 Jan;31(1):287-97. doi: 10.3892/or.2013.2822. Epub 2013 Oct 25.

PMID:
24174064
9.

The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model.

Macías-Pérez JR, Beltrán-Ramírez O, Vásquez-Garzón VR, Salcido-Neyoy ME, Martínez-Soriano PA, Ruiz-Sánchez MB, Angeles E, Villa-Treviño S.

Anticancer Drugs. 2013 Apr;24(4):394-405. doi: 10.1097/CAD.0b013e32835e9743.

PMID:
23388162
10.

Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor κ B/Rel pathway.

Chen Z, Yu B, Wu XL, Dai CQ, Qian GQ, Yu JZ, He HB, Wang ZX, Hou J, Chen XY.

Chin J Integr Med. 2012 Mar;18(3):203-8. doi: 10.1007/s11655-011-0943-4. Epub 2012 Apr 2.

PMID:
22466945
11.

[Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo].

Zhang YF, Xu GB, Gan YC, Xu XH, Xu RZ.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):1997-2001. Chinese.

PMID:
22200699
12.

Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.

Khan MS, Devaraj H, Devaraj N.

Toxicol Appl Pharmacol. 2011 Feb 15;251(1):85-94. doi: 10.1016/j.taap.2010.12.004. Epub 2010 Dec 15.

PMID:
21167192
13.

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.

Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M, Ben-Neriah Y, Pikarsky E, Angel P, Hess J.

Hepatology. 2009 Oct;50(4):1251-62. doi: 10.1002/hep.23099.

PMID:
19670424
14.

Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.

Wentz SC, Yip-Schneider MT, Gage EA, Saxena R, Badve S, Schmidt CM.

J Surg Res. 2009 Nov;157(1):e87-95. doi: 10.1016/j.jss.2008.10.006. Epub 2008 Nov 7.

PMID:
19564027
15.

Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.

Sivaramakrishnan V, Niranjali Devaraj S.

Chem Biol Interact. 2009 Aug 14;180(3):353-9. doi: 10.1016/j.cbi.2009.02.004. Epub 2009 Feb 21.

PMID:
19539802
16.

Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

Onori P, DeMorrow S, Gaudio E, Franchitto A, Mancinelli R, Venter J, Kopriva S, Ueno Y, Alvaro D, Savage J, Alpini G, Francis H.

Int J Cancer. 2009 Aug 1;125(3):565-76. doi: 10.1002/ijc.24271.

18.

Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.

Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E.

Gastroenterology. 2007 Mar;132(3):1088-103. Epub 2006 Dec 19.

PMID:
17383430
19.
20.

Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.

Cavin LG, Venkatraman M, Factor VM, Kaur S, Schroeder I, Mercurio F, Beg AA, Thorgeirsson SS, Arsura M.

Cancer Res. 2004 Oct 1;64(19):7030-8.

Supplemental Content

Loading ...
Support Center